These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Hepatocellular carcinoma in the University Hospital. Torres EA, Bravo-Fernández E. Bol Asoc Med P R; 1985 Nov; 77(11):459-60. PubMed ID: 3004530 [No Abstract] [Full Text] [Related]
54. [Increased incidence of hepatocellular carcinoma in western countries: the reasons and the consequences]. Trinchet JC, Beaugrand M. Gastroenterol Clin Biol; 1999 Dec; 23(12):1286-8. PubMed ID: 10642616 [No Abstract] [Full Text] [Related]
55. Management of hepatocellular carcinoma in homozygous β-thalassemia cirrhotic patients. Gomatos IP, Alexakis N, Koskinas J, Smparounis SA, Katsaragakis S, Konstadoulakis MM, Zografos GC. Am Surg; 2013 Jan; 79(1):111-3. PubMed ID: 23317624 [No Abstract] [Full Text] [Related]
56. Epidemiology of hepatocellular carcinoma. Bosch FX, Ribes J, Cléries R, Díaz M. Clin Liver Dis; 2005 May; 9(2):191-211, v. PubMed ID: 15831268 [Abstract] [Full Text] [Related]
57. Different clinicopathological features of hepatocellular carcinoma in relation to causative agents. Shiratori Y, Yoshida H, Omata M. J Gastroenterol; 2001 Feb; 36(2):73-8. PubMed ID: 11227674 [No Abstract] [Full Text] [Related]